Lack of amyloid plaque formation in the central nervous system of a patient with Werner syndrome

Neuropathology

Volumn 23, Issue 1, 2003, Pages 51-56

  Mori, Hiroshi ^a   Tomiyama, Takami ^a   Maeda, Naoki ^a,b   Ozawa, Kazuharu ^a   Wakasa, KenIchi ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Aging; Apolipoprotein E; Central nervous system; Senile plaque; Werner syndrome

Indexed keywords

AMYLOID PROTEIN; APOLIPOPROTEIN E;

ADULT; AGING; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CENTRAL NERVOUS SYSTEM; DELETION MUTANT; EXON; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; PRIORITY JOURNAL; SENILE PLAQUE; WERNER SYNDROME;

ADULT; AGING, PREMATURE; APOLIPOPROTEINS E; BASE SEQUENCE; BRAIN; DNA HELICASES; FRAMESHIFT MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLES; RECQ HELICASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENILE PLAQUES; SEQUENCE DELETION; WERNER SYNDROME;

EID: 0037353436     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2003.00474.x     Document Type: Article

References (20)

1. Yu CE, Oshima J, Fu YH et al. Positional cloning of the Werner's syndrome gene. Science 1996; 272: 258-262.
2. Epstein C, Martin G, Schhultz A, Motulsky A. Werner's syndrome: A review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Adv Exp Med Biol 1985; 190: 57-120.
3. Herrero F. Neurological manifestations of inheritable connective tissue disorders. In: Vinken P, Bruyn G (eds) Handbook of Neurology, Vol. 39. Amsterdam: North Holland Publications, 1980; 400-405.
4. Postiglione A, Soricelli A, Covelli EM et al. Premature aging in Werner's syndrome spares the central nervous system. Neurobiol Aging 1996; 17: 325-330.
5. Haustein J, Pawlas U, Cervos-Navarro J. The Werner syndrome: A case study. Clin Neuropathol 1989; 8: 147-151.
6. Sumi SM. Neuropathology of the Werner syndrome. Adv Exp Med Biol 1985; 190: 215-218.
7. Leverenz JB, Yu CE, Schellenberg GD. Aging-associated neuropathology in Werner syndrome. Acta Neuropathol-(Berl) 1998; 96: 421-424.
8. Hixon JE, Venier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
9. Mori H, Takio K, Ogawara M, Selkoe DJ. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J Biol Chem 1992; 267: 17082-17086.
10. Ishii K, Tamaoka A, Mizusawa H et al. Aβ1-40 but not Aβ1-42 levels in cortex correlate with apolipoprotein E e4 allele dosage in sporadic Alzheimer's disease. Brain Res 1997; 748: 250-252.
11. Endoh R, Ogawara M, Iwatsubo T, Nakano I, Mori H. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease. Brain Res 1993; 601: 164-172.
12. Kitamoto T, Tateishi J, Sawa H, Doh-Ura K. Positive transmission of Creutzfeldt-Jakob disease verified by murine kuru plaques. Lab Invest 1989; 60: 507-512.
13. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
14. Gearing M, Mori H, Mirra M. Aβ peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol 1996; 39: 395-399.
15. Ikeda K, Akiyama H, Arai T et al. A subset of senile dementia with high incidence of the apolipoprotein E epsilon 2 allele. Ann Neurol 1997; 41: 693-695.
16. El-Agnaf OM, Nagala S, Patel BP, Austen BM. Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. J Mol Biol 2001; 310: 157-168.
17. Walsh DM, Klyubin I, Fadeeva JV et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416: 535-539.
18. Kirkitadze MD, Bitan G, Teplow DB. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J Neurosci Res 2002; 69: 567-577.
19. Terry RD, Masliah E, Salmon DP et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572-580.
20. Masliah E, Terry RD, Mallory M, Alford M, Hansen LA. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 1990; 137: 1293-1297.